---
layout: default
title: Remdesivir
description: "Remdesivir çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 6 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 146
evidence_level: L1
indication_count: 6
---

# Remdesivir

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>6</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Remdesivirï¼šå¾ COVID-19 åˆ°å¤šç™¼æ€§å…§åˆ†æ³Œè…«ç˜¤

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Remdesivir å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Remdesivir æ˜¯ä¸€ç¨®æŠ—ç—…æ¯’è—¥ç‰©ï¼ŒåŸæœ¬ç”¨æ–¼ COVID-19 çš„æ²»ç™‚ã€‚TxGNN æ¨¡å‹é æ¸¬å®ƒå¯èƒ½å°**å¤šç™¼æ€§å…§åˆ†æ³Œè…«ç˜¤ (Multiple Endocrine Neoplasia)** æœ‰æ•ˆï¼Œä½†ç›®å‰**ç„¡è‡¨åºŠè©¦é©—æˆ–æ–‡ç»**ç›´æ¥æ”¯æŒé€™å€‹ç‰¹å®šé©æ‡‰ç—‡ã€‚
</p>

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| åŸé©æ‡‰ç—‡ | æ–°å‹å† ç‹€ç—…æ¯’ç–¾ç—…ï¼ˆCOVID-19ï¼‰ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | multiple endocrine neoplasiaã€HIV infectious diseaseã€feline acquired immunodeficiency syndromeã€simian immunodeficiency virus infectionã€neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matterã€homozygous familial hypercholesterolemia |
| TxGNN é æ¸¬åˆ†æ•¸ | 99.50% |
| è­‰æ“šç­‰ç´š | L5 |
| å°ç£ä¸Šå¸‚ | å·²ä¸Šå¸‚ |
| è¨±å¯è­‰æ•¸ | å¤šå¼µ |
| å»ºè­°æ±ºç­– | Hold |





## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. multiple endocrine neoplasia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.50%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>Remdesivir æ˜¯ä¸€ç¨®æ ¸è‹·é¡ä¼¼ç‰©å‰è—¥ï¼Œèƒ½å¤ æŠ‘åˆ¶ç—…æ¯’çš„ RNA ä¾è³´æ€§ RNA èšåˆé…¶ï¼ˆRdRpï¼‰ï¼Œå¾è€Œé˜»æ­¢ç—…æ¯’è¤‡è£½ã€‚å®ƒæœ€åˆæ˜¯ç‚ºäº†æ²»ç™‚ä¼Šæ³¢æ‹‰ç—…æ¯’æ„ŸæŸ“è€Œé–‹ç™¼ï¼Œå¾Œä¾†å›  COVID-19 ç–«æƒ…è€Œç²å¾—ç·Šæ€¥ä½¿ç”¨æˆæ¬Šã€‚</p>

<p>å¤šç™¼æ€§å…§åˆ†æ³Œè…«ç˜¤æ˜¯ä¸€çµ„éºå‚³æ€§ç–¾ç—…ï¼Œç‰¹å¾µæ˜¯å¤šå€‹å…§åˆ†æ³Œè…ºé«”ç™¼ç”Ÿè…«ç˜¤ã€‚é€™æ˜¯ä¸€ç¨®è…«ç˜¤æ€§ç–¾ç—…ï¼Œèˆ‡ç—…æ¯’æ„ŸæŸ“ç„¡é—œã€‚</p>

<p>ç›®å‰å°šä¸æ¸…æ¥š TxGNN æ¨¡å‹ç‚ºä½•é æ¸¬ remdesivir å°å¤šç™¼æ€§å…§åˆ†æ³Œè…«ç˜¤æœ‰æ•ˆã€‚å¯èƒ½çš„å‡è¨­åŒ…æ‹¬ï¼š</p>
<ul>
<li>çŸ¥è­˜åœ–è­œä¸­çš„é€£çµå¯èƒ½åæ˜ äº†æŸäº›å…±åŒçš„åˆ†å­é€”å¾‘</li>
<li>æ ¸è‹·é¡ä¼¼ç‰©å¯èƒ½å°å¿«é€Ÿåˆ†è£‚çš„è…«ç˜¤ç´°èƒæœ‰æŸç¨®ä½œç”¨</li>

</ul>
<p>ç„¶è€Œï¼Œé€™äº›å‡è¨­ç´”å±¬æ¨æ¸¬ï¼Œç¼ºä¹ä»»ä½•ç§‘å­¸è­‰æ“šæ”¯æŒã€‚</p>

<h3>è‡¨åºŠè©¦é©—</h3>

<p>ç›®å‰ç„¡é‡å°æ­¤ç‰¹å®šé©æ‡‰ç—‡çš„è‡¨åºŠè©¦é©—ç™»è¨˜ã€‚</p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. HIV infectious disease</span>
<span class="evidence-badge evidence-L1">L1</span>
<span class="prediction-score">99.32%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ24 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04359095" target="_blank">NCT04359095</a></td><td>PHASE2, PHASE3</td><td>COMPLETED</td><td>650</td><td>Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colom...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05587894" target="_blank">NCT05587894</a></td><td>PHASE2</td><td>RECRUITING</td><td>256</td><td>OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Rand...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04546581" target="_blank">NCT04546581</a></td><td>PHASE3</td><td>COMPLETED</td><td>593</td><td>An International Multicenter, Adaptive, Randomized Double-Blind, Placebo-Control...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05925140" target="_blank">NCT05925140</a></td><td>PHASE1</td><td>RECRUITING</td><td>1000</td><td>Comparative LUSZ Therapeutic Study of Antiviral, Antiretroviral, and Immunosuppr...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04843761" target="_blank">NCT04843761</a></td><td>PHASE3</td><td>COMPLETED</td><td>473</td><td>A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05780541" target="_blank">NCT05780541</a></td><td>PHASE3</td><td>TERMINATED</td><td>58</td><td>A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04570982" target="_blank">NCT04570982</a></td><td>N/A</td><td>UNKNOWN</td><td>200</td><td>Compassionate Use of Remdesivir and Convalescent Plasma Therapy for Treatment of...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05780463" target="_blank">NCT05780463</a></td><td>PHASE3</td><td>COMPLETED</td><td>485</td><td>A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06729593" target="_blank">NCT06729593</a></td><td>PHASE3</td><td>COMPLETED</td><td>87</td><td>A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04292730" target="_blank">NCT04292730</a></td><td>PHASE3</td><td>COMPLETED</td><td>1113</td><td>A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remd...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04582266" target="_blank">NCT04582266</a></td><td>N/A</td><td>COMPLETED</td><td>54</td><td>Pharmacokinetics and Safety of Remdesivir for Treatment of COVID-19 in Pregnant ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05605093" target="_blank">NCT05605093</a></td><td>PHASE3</td><td>TERMINATED</td><td>602</td><td>Strategies and Treatments for Respiratory Infections &amp; Viral Emergencies (STRIVE...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04280705" target="_blank">NCT04280705</a></td><td>PHASE3</td><td>COMPLETED</td><td>1062</td><td>A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and E...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02818582" target="_blank">NCT02818582</a></td><td>PHASE2</td><td>COMPLETED</td><td>38</td><td>PREVAIL IV: Double-Blind, Randomized, Two-Phase, Placebo-Controlled, Phase II Tr...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04385719" target="_blank">NCT04385719</a></td><td>PHASE2</td><td>COMPLETED</td><td>24</td><td>An Open-label, Randomized, Single Intravenous Dosing Study to Investigate the Ef...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04669990" target="_blank">NCT04669990</a></td><td>N/A</td><td>UNKNOWN</td><td>2000</td><td>Remdesivir and Convalescent Plasma Therapy for Treatment of COVID-19 Infection i...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04492475" target="_blank">NCT04492475</a></td><td>PHASE3</td><td>COMPLETED</td><td>969</td><td>A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and E...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04681430" target="_blank">NCT04681430</a></td><td>PHASE2</td><td>COMPLETED</td><td>22</td><td>Reconvalescent Plasma / Camostat Mesylate Early in Sars-CoV-2 Q-PCR (COVID-19) P...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04501978" target="_blank">NCT04501978</a></td><td>PHASE3</td><td>COMPLETED</td><td>2753</td><td>A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05780281" target="_blank">NCT05780281</a></td><td>PHASE3</td><td>COMPLETED</td><td>367</td><td>A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04292899" target="_blank">NCT04292899</a></td><td>PHASE3</td><td>COMPLETED</td><td>4891</td><td>A Phase 3 Randomized Study to Evaluate the Safety and Antiviral Activity of Remd...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05780437" target="_blank">NCT05780437</a></td><td>PHASE3</td><td>COMPLETED</td><td>1455</td><td>A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05780424" target="_blank">NCT05780424</a></td><td>PHASE3</td><td>COMPLETED</td><td>353</td><td>A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05780268" target="_blank">NCT05780268</a></td><td>PHASE3</td><td>COMPLETED</td><td>314</td><td>A Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and ...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/41136410/" target="_blank">41136410</a></td><td>2025</td><td>Article</td><td>Nature reviews. Disease primer</td><td>Acute SARS-CoV-2 infection.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33264556/" target="_blank">33264556</a></td><td>2021</td><td>Article</td><td>The New England journal of med</td><td>Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/35229634/" target="_blank">35229634</a></td><td>2022</td><td>Article</td><td>mBio</td><td>The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36097825/" target="_blank">36097825</a></td><td>2023</td><td>Article</td><td>Clinical infectious diseases :</td><td>Qualitative Subgenomic RNA to Monitor the Response to Remdesivir in Hospitalized...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33002954/" target="_blank">33002954</a></td><td>2020</td><td>Article</td><td>Current opinion in HIV and AID</td><td>Treatment of coronavirus disease 2019.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34859557/" target="_blank">34859557</a></td><td>2022</td><td>Article</td><td>HIV medicine</td><td>Retrospective evaluation of an observational cohort by the Central and Eastern E...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33864090/" target="_blank">33864090</a></td><td>2021</td><td>Article</td><td>The Journal of antimicrobial c</td><td>A combined assay for quantifying remdesivir and its metabolite, along with dexam...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32876009/" target="_blank">32876009</a></td><td>2020</td><td>Article</td><td>The American journal of tropic</td><td>It Ain&#x27;t Over Till It&#x27;s Over: The Triple Threat of COVID-19, TB, and HIV.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36165855/" target="_blank">36165855</a></td><td>2022</td><td>Article</td><td>ChemMedChem</td><td>Recent Drug Development and Medicinal Chemistry Approaches for the Treatment of ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38028857/" target="_blank">38028857</a></td><td>2023</td><td>Article</td><td>Archives of Razi Institute</td><td>A Comparative Study of Antiretroviral (Lopinavir/Ritonavir) and Remdesivir Used ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37722451/" target="_blank">37722451</a></td><td>2023</td><td>Article</td><td>Journal of pharmaceutical scie</td><td>Plasma Protein Binding Determination for Unstable Ester Prodrugs: Remdesivir and...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36347057/" target="_blank">36347057</a></td><td>2022</td><td>Article</td><td>Topics in antiviral medicine</td><td>CROI 2022: advances in antiviral therapy for HIV, COVID-19, and viral hepatitis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/35817072/" target="_blank">35817072</a></td><td>2022</td><td>Article</td><td>The Lancet. Respiratory medici</td><td>Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19: a r...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33469197/" target="_blank">33469197</a></td><td>2021</td><td>Article</td><td>Hypertension research : offici</td><td>Maternal endothelial dysfunction in HIV-associated preeclampsia comorbid with CO...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32657527/" target="_blank">32657527</a></td><td>2020</td><td>Article</td><td>Journal of the International A</td><td>SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United St...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/35073629/" target="_blank">35073629</a></td><td>2022</td><td>Article</td><td>AIDS reviews</td><td>Oral antivirals for the prevention and treatment of SARS-CoV-2 infection.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34633268/" target="_blank">34633268</a></td><td>2022</td><td>Article</td><td>Journal of chemotherapy (Flore</td><td>The use of antiviral drugs in children.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36003629/" target="_blank">36003629</a></td><td>2022</td><td>Article</td><td>Frontiers in public health</td><td>SARS-CoV-2 pre-exposure prophylaxis: A potential COVID-19 preventive strategy fo...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33847737/" target="_blank">33847737</a></td><td>2021</td><td>Article</td><td>American journal of epidemiolo</td><td>Safety of Tenofovir Disoproxil Fumarate for Pregnant Women Facing the Coronaviru...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32587649/" target="_blank">32587649</a></td><td>2020</td><td>Article</td><td>Journal of clinical medicine r</td><td>Medical Management of COVID-19: Evidence and Experience.</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. feline acquired immunodeficiency syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.07%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. simian immunodeficiency virus infection</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.07%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.03%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. homozygous familial hypercholesterolemia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.03%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰è™Ÿ | å“å | åŠ‘å‹ | æ ¸å‡†é©æ‡‰ç—‡ |
|---------|------|------|-----------|
| è¡›éƒ¨è—¥è¼¸å­—ç¬¬XXXXXXè™Ÿ | éŸ‹å¦‚æ„æ³¨å°„ç”¨æº¶æ¶²åŠ‘100æ¯«å…‹/20æ¯«å‡ | æ³¨å°„åŠ‘ | é‡åº¦æ–°å‹å† ç‹€ç—…æ¯’æ„ŸæŸ“ç—‡ |

## å®‰å…¨æ€§è€ƒé‡

å®‰å…¨æ€§è³‡è¨Šè«‹åƒè€ƒåŸå» ä»¿å–®ã€‚

ä¸»è¦æ³¨æ„äº‹é …ï¼š
- è‚åŠŸèƒ½ç•°å¸¸
- è…åŠŸèƒ½æå®³æ‚£è€…éœ€è¬¹æ…ä½¿ç”¨
- è¼¸æ³¨ç›¸é—œåæ‡‰


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**è‚è‡Ÿç–¾ç—…** ğŸŸ¡ Moderate
- æ‡‰è¬¹æ…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚

**è…è‡Ÿç–¾ç—…** ğŸŸ¢ Minor
- ä¸å»ºè­°ä½¿ç”¨æœ¬è—¥ç‰©ã€‚

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

<div class="dfi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**é…’ç²¾** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šç”¢ç”Ÿå”åŒä½œç”¨ã€‚å¯èƒ½å¢å¼·è—¥æ•ˆã€‚é¢¨éšªåŒ…æ‹¬ï¼šæ¯’æ€§å¢åŠ ã€‚
- å»ºè­°ï¼šæ‡‰å®Œå…¨é¿å…ã€‚éœ€ç›£æ¸¬ç™‚æ•ˆæˆ–ä¸è‰¯åæ‡‰ã€‚


## çµè«–èˆ‡ä¸‹ä¸€æ­¥

**æ±ºç­–ï¼šHold**

**ç†ç”±ï¼š**
é€™å€‹é æ¸¬ç¼ºä¹ä»»ä½•ç”Ÿç‰©å­¸åˆç†æ€§ã€‚Remdesivir æ˜¯ä¸€ç¨®å°ˆé–€é‡å°ç—…æ¯’ RNA èšåˆé…¶çš„æŠ—ç—…æ¯’è—¥ç‰©ï¼Œè€Œå¤šç™¼æ€§å…§åˆ†æ³Œè…«ç˜¤æ˜¯ä¸€ç¨®éºå‚³æ€§è…«ç˜¤ç–¾ç—…ï¼Œå…©è€…åœ¨ç—…ç†æ©Ÿè½‰ä¸Šæ²’æœ‰æ˜é¡¯é—œè¯ã€‚åœ¨æ²’æœ‰ä»»ä½•åŸºç¤ç ”ç©¶æˆ–è‡¨åºŠè­‰æ“šçš„æƒ…æ³ä¸‹ï¼Œä¸å»ºè­°å°‡æ­¤é æ¸¬æ¨é€²åˆ°è‡¨åºŠæ‡‰ç”¨ã€‚

**è‹¥è¦æ¨é€²éœ€è¦ï¼š**
- æ¢è¨ TxGNN æ¨¡å‹ç”¢ç”Ÿæ­¤é æ¸¬çš„å…·é«”åŸå› 
- é€²è¡ŒåŸºç¤ç ”ç©¶ç¢ºèªæ˜¯å¦å­˜åœ¨ä»»ä½•æ½›åœ¨çš„åˆ†å­æ©Ÿè½‰
- è‹¥æœ‰ä»»ä½•ç†è«–ä¾æ“šï¼Œéœ€é€²è¡Œå‰è‡¨åºŠç ”ç©¶é©—è­‰

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Diosmin]({{ "/drugs/diosmin/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Nebivolol]({{ "/drugs/nebivolol/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Cladribine]({{ "/drugs/cladribine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Alirocumab]({{ "/drugs/alirocumab/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Levamisole]({{ "/drugs/levamisole/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Remdesivirè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/remdesivir/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_remdesivir,
  title = {Remdesivirè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/remdesivir/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
